- ►diabetesjournals.org FJ Cohen, CA Neslusan, JE Conklin, X Song - Diabetes Care, 2003 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—A sample of US privately insured patients with
suspected type 2 diabetes was identified from the MarketScan Research Database
over the period of 1997–2000. Patients with type 2 diabetes were ... Cited by 42 - Related articles - BL Direct - All 6 versions
E Chantelau, R Meyer-Schwickerath - Ophthalmologica, 2003 - content.karger.com Tight blood glucose control can significantly reduce the incidence of diabetic
retinopathy, neuropathy and nephropathy. In certain patients, however,
tightening of glucose control can achieve the opposite. The Diabetes ... Cited by 13 - Related articles - BL Direct - All 5 versions
A Sasali, JL Leahy - Current Diabetes Reports, 2003 - Springer Introduction The United States and much of the world face an epidemic of type 2
diabetes that has frightening financial and soci- etal implications for the
future [1,2]. The causative factors are well known: skyrocketing incidence ... Cited by 10 - Related articles - BL Direct - All 2 versions
PH Gæde - Danish Medical Bulletin, 2006 - dadlnet.dk This review has been accepted as a thesis together with eight previously
published papers, by the University of Copenhagen, March 28, 2006 and defended
on June 1, 2006. ... Amtssygehuset Roskilde, Kardiologisk Afdeling, and ... Cited by 6 - Related articles - Cached - All 5 versions
MJ Rosenthal - Journal of the American Medical Directors Association, 2004 - Elsevier The article by Travis et al. 1 addresses important but infrequently studied
components of nursing home medicine. When tested with glucose tolerance testing,
some studies report that up to half of elderly patients with diabetes were ... Cited by 3 - Related articles - BL Direct - All 3 versions
S Goykhman, A Drincic, JC Desmangles, M … - Expert Opin. Pharmacother., 2009 - informahealthcare.com Insulin Glargine was the first long-acting insulin analog produced by
recombinant DNA technology, approved for use by the US FDA in April 2000 and by
the European Agency for the Evaluation of Medicinal Products in June, 2000. ... Cited by 2 - Related articles - All 5 versions
- ►sherbornegibbs.com [PDF] C Livingstone, GA Ferns - The British Journal of Diabetes & Vascular Disease, 2003 - dvd.sagepub.com Abstract T he insulin-like growth factor system and, in particular, insulin-like
growth factor-I (IGF-I) and insulin-like growth factor binding protein-1
(IGFBP-1) are dysregulated in type 1 and type 2 diabetes. Serum IGF-I ... Cited by 1 - Related articles - All 7 versions
C Giusti - European review for medical and pharmacological …, 2001 - europeanreview.org Abstract. – Diabetic retinopathy is a com- mon cause of vision loss in
industrialized coun- tries and it is now evident that adequate screen- ing
protocols can identify the disease at an earli- er, more treatable stage. ... Cited by 1 - Related articles - View as HTML - BL Direct - All 3 versions
